1. Home
  2. BLTE vs UBSI Comparison

BLTE vs UBSI Comparison

Compare BLTE & UBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belite Bio Inc

BLTE

Belite Bio Inc

N/A

Current Price

$129.67

Market Cap

6.0B

Sector

Health Care

ML Signal

N/A

Logo United Bankshares Inc.

UBSI

United Bankshares Inc.

N/A

Current Price

$46.34

Market Cap

6.5B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
BLTE
UBSI
Founded
2018
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
6.5B
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
BLTE
UBSI
Price
$129.67
$46.34
Analyst Decision
Strong Buy
Hold
Analyst Count
9
6
Target Price
★ $233.00
$51.67
AVG Volume (30 Days)
142.0K
★ 719.8K
Earning Date
11-12-2026
10-22-2026
Dividend Yield
N/A
★ 3.29%
EPS Growth
N/A
N/A
EPS
N/A
★ 2.77
Revenue
N/A
★ $311,957,000.00
Revenue This Year
N/A
$4.32
Revenue Next Year
N/A
$5.54
P/E Ratio
★ N/A
$16.70
Revenue Growth
★ N/A
N/A
52 Week Low
$115.41
$36.92
52 Week High
$200.00
$50.47

Technical Indicators

Market Signals
Indicator
BLTE
UBSI
Relative Strength Index (RSI) 32.18 38.14
Support Level N/A $43.26
Resistance Level $158.76 $47.77
Average True Range (ATR) 9.11 0.94
MACD -1.46 -0.31
Stochastic Oscillator 19.04 6.84

Price Performance

Historical Comparison
BLTE
UBSI

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

About UBSI United Bankshares Inc.

United Bankshares Inc is a financial holding company that provides banking services. The company operates in one segment: Community banking, which offers a full range-of-products and services through various delivery channels. Included among the banking products and services offered are the acceptance of deposits in checking, savings, time, and money market accounts; the making and servicing of personal, credit card, commercial, and floor plan loans; and the making of construction and real estate loans, as well as the origination and sale of residential mortgages in the secondary market. Also offered are trust and brokerage services, safe deposit boxes, and wire transfers.

Share on Social Networks: